---
$id: https://graph.org.ai/products/commodity/51332804
$type: Product
source: UNSPSC
code: "51332804"
title: "Butaperazine"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butaperazine

**UNSPSC Code**: 51332804
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine antagonist with the molecular formula C24H31N3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TXP4T9106S, chemically known as 1-butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazin-2-yl)- but generally known as butaperazine, which bears US NIH Compound Identifier 12598. Butaperazine most often comes in base and maleate forms. European Medicines Agency schedules Butaperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06007MIG. The term BUTAPERAZINE is an International Non-Proprietary Name. World Health Organization schedules butaperazine in its Anatomical Therapeutic Chemical (ATC) Classification. BUTAPERAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butaperazine under HS 29343090 and SITC 51578. As of Q4 2014, BUTAPERAZINE remains the US FDA Preferred Term for this commodity. Butaperazine bears US NLM identifiers UMLS ID C0006481 and NCI Concept Code C81090. SMILES: S1C2C(N(CCCN3CCN(CC3)C)C3C1CCCC3)CC(CC2)C(=O)CCC.

